Klarity Health Learning
Stagione 3
JPM 2025 key take-aways: Navigating Innovation and Investment
Stagione 2
2025 Healthcare Prections from OOP
Stagione 1
di Guorui Su
This episode delves into key takeaways from recent J.P. Morgan Healthcare Conferences, exploring the trends shaping the healthcare industry. We'll examine the surge in obesity drug development and its impact on deal-making. We will also discuss the renewed optimism for deal making in 2024, particularly for late-stage assets, and the slight reopening of the IPO window. The discussion will also highlight the growing influence of AI in drug discovery and R&D, as well as the progress and remaining challenges in cell and gene therapies. Additionally, we’ll cover the shift in care delivery toward more localized and virtual options, the importance of reducing healthcare costs, and the ongoing concerns about healthcare workforce shortages. Finally, we will consider the renewed interest in PPMs and the continued focus on technology solutions for providers and payors.
Predictions for 2025: GLP-1s tackle addiction ACA subsidies may end FDA approves more drugs AI scribes commoditized Amazon restructures healthcare
Podcast Notes: This episode examines the current state of public health in the U.S., focusing on the effects of new federal leadership and the needs of various communities. We explore challenges and opportunities in areas from cannabis regulation and food security to the well-being of older adults. Cannabis Policy: There is a call for a coordinated public health approach due to rising usage and emergency visits. A NASEM report recommends product standards and public health campaigns for high-risk groups like youth and pregnant people. More oversight of cannabis products and training for retail staff are needed. Food as Medicine: The "Food is Medicine" initiative seeks to improve health by increasing access to nutritious foods. It addresses food insecurity linked to chronic diseases. Successful programs at the state and local levels improve food security, diet, and mental health. Older Adults: The aging U.S. population requires increased public health support. Federal frameworks and initiatives, such as the Age-Friendly Public Health Systems, promote healthy aging. New Federal Leadership: New leadership could bring measures hostile to public health, with possible overhauls of health insurance and reproductive rights. Potential changes to the CDC, ACA, and Medicaid, as well as restrictions on reproductive health and LGBTQ+ protections are of concern. State Progress: Some states have made public health gains through ballot initiatives supporting paid sick leave and abortion rights. Public health requires a coordinated, holistic approach across all levels, with partnerships to promote the health of all communities.
This episode analyzes the impact of AI on the white-collar labor market and employer-sponsored health insurance. It explains how AI is transforming job roles, creating new positions, and shifting employment structures towards more contract and gig work. This shift challenges the traditional employer-sponsored health insurance model, leading to coverage gaps for non-traditional workers and financial strain on existing systems. The text explores potential solutions, such as portable benefits, health stipends, individual coverage HRAs, and hybrid employer-government models. It also suggests that companies need to modernize their benefit strategies to remain competitive in attracting and retaining talent in an AI-driven world.
MAHA updates and implication to Klarity (Feb 18, 25)